Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: A novel target for antihypertensive agents

Prostaglandins and Other Lipid Mediators

Volumn 98, Issue 3-4, 2012, Pages 69-74

  Malik, Kafait U ^a   Jennings, Brett L ^a   Yaghini, Fariborz A ^a   Sahan Firat, Seyhan ^a   Song, Chi Young ^a   Estes, Anne M ^a   Fang, Xiao R ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin II DOCA salt hypertension; Cardiovascular hypertrophy; Cytochrome P450 1B1; Inflammation; Reactive oxygen species; Renal dysfunction

Indexed keywords

ANGIOTENSIN II; BRAIN NATRIURETIC PEPTIDE; CYTOCHROME P450 1B1; DEOXYCORTICOSTERONE; ENDOTHELIN 1; HYDROXYICOSATETRAENOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; N(G) NITROARGININE METHYL ESTER; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STILBENE DERIVATIVE; TEMPOL;

BLOOD VESSEL REACTIVITY; CARDITIS; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; GENE DISRUPTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTROPHY; KIDNEY INJURY; KIDNEY PARENCHYMA; MEAN ARTERIAL PRESSURE; NEPHRITIS; NONHUMAN; ONCOGENE SRC; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR SYSTEM; CELL MOVEMENT; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; HYPERTENSION; MYOCYTES, SMOOTH MUSCLE;

EID: 84864432715     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.12.003     Document Type: Review

References (55)

1. M. Esler The sympathetic system and hypertension Am J Hypertens 13 2000 S99 S105
2. R.M. Carey Overview of endocrine systems in primary hypertension Endocrinol Metab Clin North Am 40 2011 265 277
3. 2 in vascular smooth-muscle cells Biochem J 299 1994 197 201
4. 2 in norepinephrine-induced arachidonic acid release in rabbit aortic smooth muscle cells J Biol Chem 271 1996 30149 30157
5. M.M. Muthalif, I.F. Benter, M.R. Uddin, J.L. Harper, and K.U. Malik Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells J Pharmacol Exp Ther 284 1998 388 398
6. A. Nasjletti, and K.U. Malik Interrelations between prostaglandins and vasoconstrictor hormones: contribution to blood pressure regulation Fed Proc 41 1982 2394 2399
7. J.C. McGiff Prostaglandins, prostacyclin, and thromboxanes Annu Rev Pharmacol Toxicol 21 1981 479 509
8. A. Nasjletti, and C. Arthur Corcoran Memorial Lecture: the role of eicosanoids in angiotensin-dependent hypertension Hypertension 31 1998 194 200
9. J.C. McGiff, and J. Quilley 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure Curr Opin Nephrol Hypertens 10 2001 231 237
10. K. Nozawa, M.L. Tuck, M. Golub, P. Eggena, J.L. Nadler, and N. Stern Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats Am J Physiol Heart Circ Physiol 259 1990 H1774 H1780
11. R.L. Smith, and M.J. Weidemann Reactive oxygen production associated with arachidonic acid metabolism by peritoneal macrophages Biochem Biophys Res Commun 97 1980 973 980
12. M.Y. Lee, and K.K. Griendling Redox signaling, vascular function, and hypertension Antioxid Redox Signal 10 2008 1045 1059
13. H.J. Hong, G. Hsiao, T.H. Cheng, and M.H. Yen Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats Hypertension 38 2001 1044 1048
14. S. Rajagopalan, S. Kurz, and T. Münzel Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone J Clin Invest 97 1996 1916 1923
15. U. Landmesser, S. Dikalov, and S.R. Price Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension J Clin Invest 111 2003 1201 1209
16. R.J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol Rev 82 2002 131 185
17. T. Shimada, C.L. Hayes, and H. Yamazaki Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1 Cancer Res 56 1996 2979 2984
18. T. Shimada, and Y. Fujii-Kuriyama Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1 Cancer Sci 95 2004 1 6
19. C.L. Hayes, D.C. Spink, B.C. Spink, J.Q. Cao, N.J. Walker, and T.R. Sutter 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1 Proc Natl Acad Sci USA 93 1996 9776 9781
20. D. Choudhary, I. Jansson, I. Stoilov, M. Sarfarazi, and J.B. Schenkman Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1B1 Drug Metab Dispos 32 2004 840 847
21. T.R. Sutter, Y.M. Tang, and C.L. Hayes Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2 J Biol Chem 269 1994 13092 13099
22. Y.M. Tang, Y-Y. Wo, and J. Stewart Isolation and characterization of the human CYP1B1 gene J Biol Chem 271 1996 28324 28330
23. H.M. Korashy, and A.O.S. El-Kadi The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases Drug Metab Rev 38 2006 411 450
24. M.C. McFadyen, W.T. Melvin, and G.I. Murray Cytochrome P450 enzymes: novel options for cancer therapeutics Mol Cancer Ther 3 2004 363 371
25. D.Y. Ryu, and E. Hodgson Constitutive expression and induction of CYP1B1 mRNA in the mouse J Biochem Mol Toxicol 13 1999 249 251
26. W. Zhao, A.R. Parrish, and K.S. Ramos Constitutive and inducible expression of cytochrome P450IA1 and P450IB1 in human vascular endothelial and smooth muscle cells In Vitro Cell Dev Biol Anim 34 1998 671 673
27. J.K. Kerzee, and K.S. Ramos Constitutive and inducible expression of Cyp1a1 and Cyp1b1 in vascular smooth muscle cells. Role of the Ahr bHLH/PAS transcription factor Circ Res 89 2001 573 582
28. D.E. Conway, Y. Sakurai, and D. Weiss Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress Cardiovasc Res 81 2009 669 677
29. Y. Tang, E.A. Scheef, and S. Wang CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression Blood 113 2009 744 754
30. F.A. Yaghini, C.Y. Song, and E.N. Lavrentyev Angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation Hypertension 55 2010 1461 1467
31. C.S. Wilcox, and A. Pearlman Chemistry and antihypertensive effects of tempol and other nitroxides Pharmacol Rev 60 2008 418 469
32. B.L. Jennings, S. Sahan-Firat, and A.M. Estes Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology Hypertension 56 2010 667 674
33. J.T. Crofton, L. Share, R.E. Shade, W.J. Lee-Kwon, M. Manning, and W.H. Sawyer The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat Hypertension 1 1979 31 38
34. J. de Champlain, M. Bouvier, and G. Drolet Abnormal regulation of the sympathoadrenal system in deoxycorticosterone acetate-salt hypertensive rats Can J Physiol Pharmacol 65 1987 1605 1614
35. G. Drolet, M. Bouvier, and J. de Champlain Enhanced sympathoadrenal reactivity to haemorrhagic stress in DOCA-salt hypertensive rats J Hypertens 7 1989 237 242
36. E.L. Schiffrin, P. Sventek, J.S. Li, A. Turgeon, and T. Reudelhuber Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats Br J Pharmacol 115 1995 1377 1381
37. 2+ dependent activation of phospholipase A2 J Clin Invest 82 1988 168 176
38. L. Trevisi, S. Bova, G. Cargnelli, G. Ceolotto, and S. Luciani Endothelin-1 induced arachidonic acid release by cytosolic phospholipase A2 activation in rat vascular smooth muscle via extracellular signal-regulated kinases pathway Biochem Pharmacol 264 2000 425 431
39. S. Sahan-Firat, B.L. Jennings, and F.A. Yaghini 2,3(,4,5(- Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1 Am J Physiol Heart Circ Physiol 299 2010 H1891 H1901
40. M. Sarr, M. Chataigneau, and S. Martins Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase Cardiovasc Res 71 2006 794 802
41. T. Mori, and A.W Cowley Jr. Role of pressure in angiotensin II-induced renal injury. Chronic servo-control of renal perfusion pressure in rats Hypertension 43 2004 752 759
42. C. Jin, C. Hu, and A. Polichnowski Effects of renal perfusion pressure on renal medullary hydrogen peroxide and nitric oxide production Hypertension 53 2009 1048 1053
43. R. Agarwal Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade Am J Physiol Renal Physiol 284 2003 F863 F869
44. J.F. Reckelhoff, and J.C. Romero Role of oxidative stress in angiotensin-induced hypertension Am J Physiol Regul Integr Comp Physiol 284 2003 R893 R912
45. W.J. Welch, J. Blau, H. Xie, T. Chabrashvili, and C.S. Wilcox Angiotensin-induced defects in renal oxygenation: role of oxidative stress Am J Physiol Heart Circ Physiol 288 2005 H22 H28
46. B.L. Jennings, L.J. Anderson, and A.M. Estes Involvement of cytochrome P450 1B1 to renal dysfunction, injury and inflammation associated with angiotensin II-induced hypertension in rats Am J Physiol Renal Physiol 2011 [November 16, Epub ahead of print, doi:10.1152/ajprenal.00542.2011]
47. B.L. Jennings, L.J. Anderson, and A.M. Estes Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice Hypertension 2011 [Epub ahead of print]
48. A.J. Polichnowski, L. Lu, and A.W Cowley Jr. Renal injury in angiotensin II + l-NAME-induced hypertensive rats is independent of elevated blood pressure Am J Physiol Renal Physiol 300 2011 F1008 F1016
49. M. Medhora, Y. Chen, and S. Gruenloh 20-HETE increases superoxide production and activates NADPH oxidase in pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol 294 2008 L902 L911
50. Y. Wen, J. Gu, G.E. Vandenhoff, X. Liu, and J.L. Nadler Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages Am J Physiol Heart Circ Physiol 2008 H1933 H1938
51. A.A. Eid, Y. Gorin, and B.M. Fagg Mechanisms of podocyte injury in diabetes. Role of cytochrome P450 and NADPH oxidases Diabetes 58 2009 1201 1211
52. A.N.D. Cat, and R.M. Touyz Cell signaling of angiotensin II on vascular tone: novel mechanisms Curr Hypertens Rep 13 2011 122 128
53. 1 receptor: novel insights into mechanisms and pathophysiology Clin Sci 112 2007 417 428
54. G.E. Callera, A.C.I. Montezano, and A. Yogi Responses to c-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats Hypertension 46 2005 1032 1038
55. P.K. Mehta, and K.K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol 292 2007 C82 C97